The use of DIY (Do it yourself) sampling and telemonitoring model for COVID-19 qPCR testing scale up

Author:

Amoo Olufemi Samuel,Adewara Funmi,Tijani Bosun,Onuigbo Tochukwu IfeanyiORCID,Ikemefuna Amaka Stephanie,Oraegbu Joy Isioma,Rizvi Tazeen,Okwuraiwe Azuka,Onwuamah Chika,Shaibu Joseph,James Ayorinde,Ohihoin Greg,Ige Fehintola,Kareithi DorcasORCID,David Agatha,Karera StevenORCID,Agboola Hammed,Adeniyi Anthony,Obi Josephine,Achanya Dominic,Odewale Ebenezer,Oforomeh Osaga,Liboro Gideon,Nwogbe Olayemi,Ezechi Oliver,Adegbola Richard,Audu Rosemary,Salako Babatunde

Abstract

The first case of COVID-19 in Nigeria was recorded on February 27, 2020, being an imported case by an Italian expatriate, to the country. Since then, there has been steady increase in the number of cases. However, the number of cases in Nigeria is low in comparison to cases reported by other countries with similar large populations, despite the poor health system prevailing in the country. This has been mainly attributed to the low testing capacity in Nigeria among other factors. Therefore, there is a need for innovative ways to increase the number of persons testing for COVID-19. The aim of the study was to pilot a nasopharyngeal swab self-sample collection model that would help increase COVID-19 testing while ensuring minimal person-to-person contact being experienced at the testing center. 216 participants took part in this study which was carried out at the Nigerian Institute of Medical Research between June and July 2020. Amongst the 216 participants, 174 tested negatives for both self-collected samples and samples collected by Professionals, 30 tested positive for both arms, with discrepancies occurring in 6 samples where the self-collected samples were positive while the ones collected by the professionals were negative. The same occurred in another set of 6 samples with the self-collected samples being negative and the professional—collected sample coming out positive, with a sensitivity of 83.3% and a specificity of 96.7%. The results of the interrater analysis are Kappa = 0.800 (95% CI, 0.690 to 0.910) which implies an outstanding agreement between the two COVID-19 sampling methods. Furthermore, since p< 0.001 Kappa (k) coefficient is statistically different from zero, our findings have shown that self-collected samples can be reliable in the diagnosis of COVID-19.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Coronaviruses: An Overview of Their Replication and Pathogenesis;AR Fehr;Methods in Molecular Biology,2015

2. Molecular mechanisms of severe acute respiratory syndrome (SARS);DA Groneberg;Respir Res,2005

3. 2005. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus;SR Weiss;Microbiology and molecular biology reviews,2005

4. Drug targets for corona virus: A systematic review;M Prajapat;Indian J Pharmacol,2005

5. COVID and the convergence of three crises in Europe;K. Bozorgmehr;The Lancet Public Health,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3